NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Update

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 900 shares, a decrease of 95.0% from the November 30th total of 18,100 shares. Based on an average trading volume of 23,300 shares, the short-interest ratio is presently 0.0 days.

NLS Pharmaceutics Stock Performance

NLSPW traded down $0.01 during midday trading on Friday, reaching $0.01. The company’s stock had a trading volume of 13,555 shares, compared to its average volume of 21,356. The company has a fifty day simple moving average of $0.01 and a 200 day simple moving average of $0.02. NLS Pharmaceutics has a twelve month low of $0.01 and a twelve month high of $0.10.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).